Código QR

Diagnostic efficacy of brafv600e immunocytochemistry in thyroid aspirates in bethesda category iv and papillary thyroid carcinoma

Background: In papillary thyroid carcinoma (PTC), BRAFV600E is a common mutation and is associated with aggressive clinical behaviour. Immunocytochemistry (ICC) and molecular testing are recommended in the Bethesda System for Reporting Thyroid Cytopathology 2017 (TBSRTC) category III, IV and V. Aims...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Nidhi Anand, Tushar Agrawal, Anurag Gupta, Saumya Shukla, Roma Pradhan, Nuzhat Husain
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Cytology
Assuntos:
Acceso en liña:http://www.jcytol.org/article.asp?issn=0970-9371;year=2021;volume=38;issue=3;spage=113;epage=119;aulast=Anand
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!